Purchase Order 75N95024P00151
Award Date 3/1/24
Potential Completion Date 3/31/24
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hopkinton, MA 01748, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Center for Advancing Translational Sciences (NCATS) awarded a $62,000 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the delivery of COVID-19 high throughput homogeneous assays for the detection of SARS-CoV-2 proteins in 384-well plates. This award, which did not utilize a set-aside, was made on April 15, 2020 with a completion date of October 31, 2020 under the Coronavirus COVID-19 national interest action. Revvity Health Sciences, Inc. is a subsidiary of...
- The Department of Health and Human Services' National Institutes of Health (NIH) Clinical Center awarded a $101,599.04 firm fixed-price purchase order to Revvity Health Sciences, Inc. to provide COVID-19 related equipment and reagents. The award has a Coronavirus COVID-19 National Interest Action Code and was completed on April 10, 2020, shortly after the initial contract award on April 6, 2020. No set-aside designation was used for this award. Revvity Health Sciences, Inc. is a for-profit...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Revvity Health Sciences, Inc. for a GENE ASSAY SYSTEM 1000ML with a potential value of $13,959.00. The contract has a completion date of September 28, 2018. Revvity Health Sciences, Inc. is a for-profit manufacturer of medical imaging products and services that has received numerous prime contracts and subcontracts from...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Revvity Health Sciences, Inc. to provide STEADYLITE PLUS KITS. The award, valued at $23,891.30, does not have a set-aside designation and was completed on June 24, 2020. Revvity Health Sciences, Inc. is a for-profit organization and manufacturer of goods that has previously received federal prime...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order contract to Revvity Health Sciences, Inc. for a Steadylite Plus Reporter Gene Assay Reagent System. The $23,209.50 contract does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that has provided a variety of medical devices and equipment, including automation systems for genetic...
- Revvity Health Sciences, Inc., a division of Revvity Inc. Medical Imaging, LLC, has been awarded a firm fixed price purchase order valued at fourteen thousand six hundred fifteen dollars ($14,615) by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract calls for Revvity Health Sciences to provide ALPHALISA HIV P24 (HS) KITS (AMBIS #2184099) with performance taking place in Shelton, Connecticut over the...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,670.60 firm-fixed-price purchase order to Revvity Health Sciences, Inc. for the STEADYLITE PLUS 1000ML KIT. The contract, which does not have a set-aside designation, was awarded on August 1, 2019 with a completion date of August 23, 2019. Revvity Health Sciences, Inc. is a for-profit manufacturer that provides medical imaging products and services to...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Revvity Health Sciences, Inc. for the supply of a Perkin Elmer brand-name product. The $125,670.00 contract has a period of performance from August 1, 2019 to July 31, 2020 and does not have a set-aside designation. Revvity Health Sciences is a for-profit manufacturer that provides medical imaging products...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Revvity Health Sciences, Inc. for the delivery of analytical development consumable supplies to support the Vaccine Production Program's therapeutic and vaccine candidates. The $128,403.24 contract includes protein reagents, DNA/RNA labchips, and shipping for four deliveries between July 2024 and April 2025. This procurement was competed as a Request for Quotes (RFQ) under Simplified...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Revvity Health Sciences, Inc. for $20,685.50. The contract calls for Revvity to deliver 10,000 test kits of its proprietary Revvity HTRF SARS-CoV-2 capsid kit to the agency's specified delivery location in Rockville, Maryland by March 31, 2024. The solicitation sought this specific kit, which uses a homogeneous time-resolved fluorescence assay to measure SARS-CoV-2 nucleocapsid antibodies in cultured media and lysates. No set-aside was used for this award to supply a proprietary product aligned with the agency's biomedical research mission.
Generated 2/22/24, 9:04 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Revvity 10, 000 test HTRF SARS-CoV2 capsid kit (Brand Name Only) | 75N95024Q00095 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 2/6/24, 9:05 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 2/21/24 |